Buprenorphine Prescribing for Pediatric Patients in the Emergency Department
This podcast will be published on the SAEM website and in promotional materials, such as our weekly newsletter, to inform learners of the activity’s contents and goals.
PCSS-MOUD Online Case-based Learning Collaborative – Session 4: Methadone in the era of Fentanyl
Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on Hospital Based Approaches to OUD and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.
PCSS MOUD Online Case-based Learning Collaboratives Session 2: Hospital Based Approaches to OUD
Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on Hospital Based Approaches to OUD and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.
PCSS MOUD Online Case-based Learning Collaboratives Session 1: OUD and Pregnancy
Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on OUD and Pregnancy and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.
Initiating Buprenorphine for Patients Using Fentanyl
This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The presenters will review the evidence for and describe low dose buprenorphine initiation of protocols, high dose buprenorphine initiation of protocols, approaches to help support patients stop using full agonist opioids for a longer period of time, and a clinical approach to referring patients to alternative medications for opioid use disorder.
20: Treating Pregnant People for Opioid Use Disorder: Clinical Challenges
Opioid use disorder (OUD) among women and people who become pregnant is increasing in prevalence in clinical settings. The standard of care is to provide buprenorphine or methadone as a part of a complete treatment approach during pregnancy and beyond the postpartum period. This module reviews the historical and current context of opioid use among women and birthing people during pregnancy. It compares pharmacological treatment options for women and people who become pregnant with an OUD and also discusses the issues with detoxification or medically assisted withdrawal from opioids during pregnancy. Issues related to the treatment of OUD during pregnancy and in the postpartum period for the birthing person, fetus and child will also be discussed (e.g., induction, dosing, pain management, neonatal withdrawal and how to reduce its severity).
Neonatal Abstinence Syndrome Resources
The National Center on Substance Abuse and Child Welfare (NCSACW) is highlighting resources on best practices in the treatment of opioid use disorders and Neonatal Abstinence Syndrome. NCSACW is a national resource center providing information, expert consultation, training and technical assistance to child welfare, dependency court, and substance abuse treatment professionals to improve the safety, permanency, well-being, and recovery outcomes for children, parents, and families.
SAMHSA MAT Guide for Pregnant Women with OUD
SAMHSA, in collaboration with the Administration on Children, Youth, and Families, developed this guide promoting collaborative efforts among agencies and providers serving pregnant and postpartum women with opioid dependence and their infants. This publication includes an overview of the extent of opioid use by pregnant women and evidence-based recommendations for treatment approaches from leading professional organizations.
